Literature DB >> 20635561

Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: the FAMA study.

Daniel Bonhorst1, Miguel Mendes, Pedro Adragão, João De Sousa, João Primo, Eva Leiria, Pedro Rocha.   

Abstract

INTRODUCTION: Atrial fibrillation (AF) is the most frequently encountered arrhythmia in clinical practice, and is an important cause of morbidity and an independent risk factor for overall mortality and sudden death. This study aims to assess the prevalence of AF in individuals aged 40 and over in order to characterize the situation in Portugal and improve the detection and management of this arrhythmia.
METHODS: This was a cross-sectional study of a representative sample of the Portuguese population including subjects of both genders aged 40 and over, resident in Portugal. The sample was constructed using a random route method. The determination of AF prevalence was based on the results of ECGs, the rhythm being classified by a panel of cardiologists; a questionnaire was used to characterize the AF population by collecting demographic, socioeconomic, clinical, and therapeutic data.
RESULTS: Of the 10,447 individuals included, 55% were female and the median age was 58 years (min=40; max=101). Two hundred and sixty-one cases of AF were identified, representing a prevalence of 2.5% (2.2-2.8%: 95% CI). No differences were found between genders, but AF prevalence increased with age, the prevalence being significantly higher in the group aged 70 and over (70-79: 6.6%; 80 and over: 10.4%). According to this study, the typical AF patient has a median age of 77, is overweight (mean BMI = 27.7 kg/m2), and does not exercise, smoke or consume alcohol. Logistic regression analysis identified male gender (OR: 1.689), age (OR: 1.094), BMI (OR: 1.056), hypertension (OR: 1.437), and lack of physical exercise (OR: 0.436) as risk factors. Only 1.6% of AF cases had known AF, usually diagnosed by a cardiologist (61%) based on an ECG (97.4%). Less than half of the patients were taking oral anticoagulants (38%).
CONCLUSIONS: AF prevalence in the Portuguese population aged 40 and over is relatively high compared to studies carried out in other countries. As AF is a common arrhythmia and is a risk factor for stroke, it is essential to promote prevention strategies. It is important to control hypertension, reduce obesity, and establish screening programs in order to maximize the number of identified cases and optimize those patients' treatment, particularly in preventing the associated thromboembolic risk.

Entities:  

Mesh:

Year:  2010        PMID: 20635561

Source DB:  PubMed          Journal:  Rev Port Cardiol        ISSN: 0870-2551            Impact factor:   1.374


  7 in total

Review 1.  The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Authors:  Pedro Silva Cunha; Sérgio Laranjo; Jordi Heijman; Mário Martins Oliveira
Journal:  Front Cardiovasc Med       Date:  2022-07-04

2.  Cardiac arrhythmias in patients presenting with COVID-19 treated in Portuguese hospitals: A national registry from the Portuguese Association of Arrhythmology, Pacing and Electrophysiology.

Authors:  Dinis Mesquita; Pedro Carmo; Nuno Cabanelas; Nuno Santos; Vítor Martins; Victor Sanfins; Helena Cristina Costa; José Paulo Fontes; Paulo Fonseca; Leonor Parreira
Journal:  Rev Port Cardiol       Date:  2021-03-15       Impact factor: 1.374

3.  Dabigatran for stroke prevention in nonvalvular atrial fibrillation: answers to challenging "real-world" questions.

Authors:  Jorge Ferreira; Daniel Ferreira; Miguel Viana-Baptista; Paulo Bettencourt; Rui Cernadas; Francisco Crespo
Journal:  Thrombosis       Date:  2012-05-07

4.  AF-React study: atrial fibrillation management strategies in clinical practice-retrospective longitudinal study from real-world data in Northern Portugal.

Authors:  Susana Silva Pinto; Andreia Teixeira; Teresa S Henriques; Hugo Monteiro; Carlos Martins
Journal:  BMJ Open       Date:  2021-03-29       Impact factor: 2.692

5.  Genetic and Metabolic Determinants of Atrial Fibrillation in a General Population Sample: The CHRIS Study.

Authors:  David B Emmert; Vladimir Vukovic; Nikola Dordevic; Christian X Weichenberger; Chiara Losi; Yuri D'Elia; Claudia Volpato; Vinicius V Hernandes; Martin Gögele; Luisa Foco; Giulia Pontali; Deborah Mascalzoni; Francisco S Domingues; Rupert Paulmichl; Peter P Pramstaller; Cristian Pattaro; Alessandra Rossini; Johannes Rainer; Christian Fuchsberger; Marzia De Bortoli
Journal:  Biomolecules       Date:  2021-11-09

6.  The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification.

Authors:  Gareth J Wynn; Derick M Todd; Matthew Webber; Laura Bonnett; James McShane; Paulus Kirchhof; Dhiraj Gupta
Journal:  Europace       Date:  2014-02-16       Impact factor: 5.214

7.  Prevalence and Risk Factors of Atrial Fibrillation in Chinese Elderly: Results from the Chinese Longitudinal Healthy Longevity Survey.

Authors:  Choy-Lye Chei; Prassanna Raman; Chi Keong Ching; Zhao-Xue Yin; Xiao-Ming Shi; Yi Zeng; David B Matchar
Journal:  Chin Med J (Engl)       Date:  2015-09-20       Impact factor: 2.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.